APA (7th ed.) Citation

RK, S., NBB, M., & CJ, D. (2024). Galectin-9 - ligand axis: An emerging therapeutic target for multiple myeloma. Frontiers in immunology, 15, 1469794. https://doi.org/10.3389/fimmu.2024.1469794

Chicago Style (17th ed.) Citation

RK, Shil, Mohammed NBB, and Dimitroff CJ. "Galectin-9 - Ligand Axis: An Emerging Therapeutic Target for Multiple Myeloma." Frontiers in Immunology 15 (2024): 1469794. https://doi.org/10.3389/fimmu.2024.1469794.

MLA (9th ed.) Citation

RK, Shil, et al. "Galectin-9 - Ligand Axis: An Emerging Therapeutic Target for Multiple Myeloma." Frontiers in Immunology, vol. 15, 2024, p. 1469794, https://doi.org/10.3389/fimmu.2024.1469794.